The range of therapeutic efficacy of atypical antipsychotics: a critical evaluation-Reference-Cited by-同舟云学术

The range of therapeutic efficacy of atypical antipsychotics: a critical evaluation

Published:2003-08 Issue:2 Volume:61 Page:259-264
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Dimova Aleksandra

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Broad therapeutic uses of atypical antipsychotic medications;Buckley;Biol. Psychiatry,2001

2. Naturalistic study of olanzepine in treatment-resistant schizophrenia and acute mania, depression and obsessional disorder;Ohaeri;East Afr. Med. J.,2000

3. Amisulpride, an unusual ‘atypical’ antipsychotic: a meta-analysis of randomized controlled trials;Leucht;Am. J. Psychiatry,2002

4. Olanzapine: an updated review of its use in the management of schizophrenia;Bhana;Drugs,2001

5. Quetiapine: a review of its safety in the management of schizophrenia;Dev;Drug Saf.,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs;Handbook of Clinical Neurology;2011

2. The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action;Pharmacology & Therapeutics;2010-05

3. Interpretive flexibility: why doesn't insight incite controversy in mental health law?;Behavioral Sciences & the Law;2007-01

4. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder;Human Psychopharmacology: Clinical and Experimental;2007

5. Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?;Movement Disorders;2006-05